CMS Withdraws Medicaid Cell, Gene Therapy Price ‘Verification’ Survey Plan

 
• By Cathy Kelly
  
The Audit Plan Would Have Exceeded Agency Authority, Critics Said. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet